维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="VERDALLES U"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk 显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
2	Factors predicting mortality in elderly patients on dialysis显示文摘	Verdalles U Abad S Aragoncillo I	2010	Nephron Clin Pract2010，115，1：	1
3	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
4	Allop- urinol and progression of CKD and cardiovascular events : long- term follow-up of a randomizedclinical trial 显示文摘	Goicoechea M Garcia de Vinuesa S Verdalles U	2015	Am J Kidney Dis2015，65，4：	1
5	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk显示文摘	GOICOECHEA M de VINUESA S G VERDALLES U		0，，08：	1
6	Ampuero J,Jofre R, Lopez-Gomez JM显示文摘	Verdalles U Abad S Vega A	2011	Blood Purif2011，32，1：	1
7	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk 显示文摘	Goicoeehea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
8	Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk显示文摘	Goicoechea M Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
9	Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial 显示文摘	Goieoechea M Garcia DVS Verdalles U	2015	Am J Kidney Dis2015，65，4：	1
10	Cardiovascular events and mortality in chronic kidney disease ( stages I - IV) 显示文摘	Quiroga B Verdalles U Reque J	2013	Ne- frologia2013，33，4：	1
11	Factors related to the absence of anemia in hemodialysis patients显示文摘	VERDALLES U ABAD S VEGA A	2011	Blood Purif2011，32，1：	1
12	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
13	Effect of allop- urinol in chronic kidney disease progression and cardiovascular risk显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
14	Efict of allopurinol in chronic kidney disease progression and cardiovascular risk 显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin JAm Soc Nephrol2010，5，8：	1
15	Effect ofallopurinol in chronic kidney disease progression and cardiovas-cular risk显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
16	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk显示文摘	Goicoechea M De Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
17	Effect of allopurinol on chronic kidney disease progression and cardiovascular risk显示文摘	Goicoechea M Garcia de Vinuesa S Verdalles U	2010	Clin J Am Soc Nephrol2010，5，8：	1
18	Effect of allo- purinol in chronic kidney disease progression and cardiovascular risk 显示文摘	Goicoechea M de Vinuesa SG Verdalles U	2010	Clin J Am Soc Nephml2010，5，8：	1
19	Dose equivalence be- tween continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kid- ney disease显示文摘	Vega A Abad S Verdalles U	2014	HIPPOKRATIA2014，18，4：	1
20	Allopurinol and progression of CKD and cardiovascular events: long-term fol- low-up of a iandomized clinical trial显示文摘	Goicoechea M Garcia de Vinuesa S Verdalles U	2015	Am J Kidney Dis2015，65，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示